✦ LIBER ✦

A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors

✍ Scribed by Herbert I. Hurwitz; Roger B. Cohen; J. Patrick McGovren; Samit Hirawat; William P. Petros; Yutaka Natsumeda; Tomoko Yoshinari

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of edo

✍ Yasuhide Yamada; Tomohide Tamura; Noboru Yamamoto; Tatsu Shimoyama; Yutaka Ueda; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 266 KB

A phase I pharmacokinetics study of 9-ni

✍ Zhao Yan; Zhongling Zhu; Kai Li; Peng Chen; Liuchun Wang; Chun Huang; Jinhuai Xu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 209 KB

A Phase I study to assess the safety, to

✍ J. R. Infante; R. Kurzrock; J. Spratlin; H. A. Burris; S. G. Eckhardt; J. Li; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB

Safety and pharmacokinetics of high-dose

✍ Mitchell E. Gross; Lawrence Leichman; Elizabeth S. Lowe; Alan Swaisland; David B 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 432 KB

A phase I and pharmacokinetic study of p

✍ Claire F. Verschraegen; Keith Skubitz; Adil Daud; Andrzej P. Kudelka; Ian Rabino 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 310 KB

A phase I study of bortezomib and temozo

✍ J. Portnow; P. Frankel; S. Koehler; P. Twardowski; S. Shibata; C. Martel; R. Mor 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 384 KB